AUG 05, 2016 08:36 AM PDT

Heart Disease Linked to Men With HIV & Inflammatory Biomarkers

WRITTEN BY: Kara Marker
Medical approaches for treating infections of human immunodeficiency virus (HIV) have come a long way in the past few decades, with antiretroviral therapy (ART) helping people living with HIV live longer lives. However, HIV patients are uniquely vulnerable to chronic illnesses like coronary artery disease (CAD) and prone to developing them earlier than people not infected with HIV. A new study from the University of Southern California confirms this connection. 
In their study published in the Journal of the American Heart Association, Southern California researchers conducted a study of 975 men living with HIV and 575 men without the infection from the Multicenter AIDS Cohort Study. They used computed tomography (CT) angiography to detect “subclinical CAD,” meaning they could detect signs of disease in the arteries before the patients actually started showing symptoms. 

CT angiography is a non-invasive imaging study that provides detailed information about a person’s blood vessels and their relationship with other organs in the body. Using CT angiography in their study, Southern California researchers could observe narrowing of the arteries as well as the amount, density, and calcification of any plaque deposits that had begun to form. 

In addition, the researchers looked for the presence of seven different inflammatory biomarkers in the same study participants, making the study the largest ever CT scan imaging study on men living with HIV.

Their results showed an overall higher level of inflammatory markers associated with the men with HIV infections in comparison to the men without HIV. Plus, the men with HIV were more likely to have signs of subclinical CAD. The study authors stressed that their results proved correlation between inflammatory markers and increased prevalence of CAD, not causation.

“It is suggestive of a possible role that persistent inflammation may play in increasing the risk of heart disease in [HIV] patients,” said study leader Hossein Bahrami, MD, PhD. More diverse types of inflammatory markers tested in the study than ever before, so scientists could learn a thing or two about HIV and the inflammatory pathway in addition to HIV patients’ risk for developing coronary artery disease. 

Inflammation in HIV patients is associated with their tendency toward accelerated aging as well as an increased risk for “non-AIDS-defining illnesses.” With further research, scientists could get even closer to determining how chronic inflammation and CAD are related in HIV patients, potentially leading someday to a treatment for one or even both conditions.
 


Sources: University of Southern California Health Sciences, AIDS Research and Human Retroviruses, Society for Vascular Surgery 
About the Author
  • I am a scientific journalist and enthusiast, especially in the realm of biomedicine. I am passionate about conveying the truth in scientific phenomena and subsequently improving health and public awareness. Sometimes scientific research needs a translator to effectively communicate the scientific jargon present in significant findings. I plan to be that translating communicator, and I hope to decrease the spread of misrepresented scientific phenomena! Check out my science blog: ScienceKara.com.
You May Also Like
MAY 01, 2018
Immunology
MAY 01, 2018
A Vaccine for When Horses Get the Flu
Horses, like humans, are susceptible to infections by the influenza virus. And like other animals, horses are capable of spreading the flu to humans, so va...
JUN 12, 2018
Cancer
JUN 12, 2018
CD44 Insights & Cancer Influence
CD44 is a known cell surface protein involved in numerous interactions; it is overexpressed in cancerous tissue and its isoforms are being investigated as targets for cancer immunotherapy...
JUN 25, 2018
Immunology
JUN 25, 2018
An Emerging Chronic Food Allergy: Eosinophilic Esophagitis
There’s a new food allergy in town, and it seems that children with existing allergies at an increased risk of developing it. From the Children&rsquo...
JUN 28, 2018
Immunology
JUN 28, 2018
Synthetic T Cells the Next Big Thing in Immunotherapy
The highly complex structure and function of human T cells made the creation of synthetic versions of the immune cells difficult, but scientists from Unive...
JUL 19, 2018
Videos
JUL 19, 2018
Hazmat Spill at Johns Hopkins
Biohazards are a common problem in any kind of scientific research, and if a spill of dangerous materials occurs, it can be deadly. Luckily, a recent spill...
AUG 08, 2018
Immunology
AUG 08, 2018
Doxorubicin Causes Heart Toxicity by Immune System Disruption
Chemotherapy drug Doxorubicin disrupts metabolism that controls immune responses in the heart leading to heart toxicity....
Loading Comments...